Dulac Edward J III
EVP, Chief Financial Officer · 4 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-02 | NTLA | Intellia Therapeutics, Inc. | Sale | 4,677 | $18.00 | $84,186.00 | filing |
| 2026-03-01 | NTLA | Intellia Therapeutics, Inc. | Award | 61,280 | $0.00 | $0.00 | filing |
| 2026-01-05 | NTLA | Intellia Therapeutics, Inc. | Sale | 6,379 | $9.21 | $58,750.59 | filing |
| 2025-07-23 | NTLA | Intellia Therapeutics, Inc. | Sale | 7,462 | $14.02 | $104,617.24 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.